Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Remedly
AddedFeb 15, 2024
UpdatedJun 18, 2026
Remedly

Remedly

Series A

Remedly offers a cloud-based ERP system for medical practices, integrating management, marketing, and analytics.

HQ
San Francisco, CA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Remedly, founded with the mission to enhance the efficiency and profitability of medical practices, offers a comprehensive cloud-based ERP system. Their platform integrates Electronic Health Records (EHR), Revenue Cycle Management (RCM), practice management, marketing, and analytics into a single, customizable solution. This integration aims to streamline day-to-day operations for physicians and provide patients with a seamless online concierge service. Remedly focuses on improving patient care while ensuring that private practices remain financially viable.

Notable figures affiliated with Remedly include key investors and advisors from the healthcare and technology sectors, although specific names are not disclosed. The company has achieved significant milestones in enhancing practice efficiency and patient care through its innovative technology. Remedly's impact is evident in its ability to transform traditional medical practice management into a more data-centric and patient-friendly approach, fostering true partnerships with its clients and contributing to the overall advancement of healthcare management technology.

Remedly - Similar Companies

Remote Care Partners logo

Remote Care Partners

Rymedi logo

Rymedi

NexHealth logo

NexHealth

nexhealth.com

RxVantage logo

RxVantage

rxvantage.com

Doctible logo

Doctible

doctible.com

Remedify logo

Remedify

remedify.com

Gradia Health logo

Gradia Health

gradia.com

Healthie logo

Healthie

gethealthie.com

Enable Healthcare logo

Enable Healthcare

Health-e-MedRecord logo

Health-e-MedRecord

SteadyMD logo

SteadyMD

steadymd.com

MedClimate logo

MedClimate

Epimedica logo

Epimedica

Dhrpro logo

Dhrpro

dhrpro.com

HealerPlus logo

HealerPlus

healerplus.com

Remedly - Quick Facts

Who are Remedly's competitors?

Companies similar to Remedly include Remote Care Partners, Rymedi, NexHealth and RxVantage.

When was Remedly founded?

Remedly was founded in 2014.

Where is Remedly's headquarters located?

Remedly's headquarters is located in San Francisco, CA, US.

When was Remedly's last funding round?

Remedly's most recent funding round was for $250k (USD) in January 2023.

How much has Remedly raised to-date?

As of Jan 3, 2023, Remedly has raised a total of $10.6M (USD).

How many employees does Remedly have?

Remedly has 13 employees as of Feb 5, 2024.

Remedly - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • Cloud
  • SaaS
Geographic Exposure
  • United States
Revenue
  • Recurring
Main Product
  • EHR
  • Practice Management
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software